EGFR and non-small cell lung carcinoma: Thus, in the present study, we aimed to validate EV-based BALF EGFR genotyping prospectively for a large sample size in a real clinical setting of 224 patients with advanced non-squamous NSCLC who need urgent therapeutic intervention.